{"database": "lobbying", "table": "lobbying_activities", "rows": [[2430203, "19b03fe6-29ff-4d59-9d6e-3969aaf4eeb5", "Q1", "COVINGTON & BURLING LLP", 11195, "PERSONAL CARE PRODUCTS COUNCIL", 2020, "first_quarter", "CSP", "OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 726), Humane Cosmetics Act, Cosmetic Safety Enhancement Act of 2019 (H.R. 5279).\nThe FDA's proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2020-04-17T08:52:55.197000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2430203"], "units": {}, "query_ms": 0.4684360173996538, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}